Literature DB >> 9460032

The heroin epidemic in New York City: current status and prognoses.

A Hamid1, R Curtis, K McCoy, J McGuire, A Conde, W Bushell, R Lindenmayer, K Brimberg, S Maia, S Abdur-Rashid, J Settembrino.   

Abstract

Since 1989, heroin production worldwide has risen; in New York City, as its purity rose and prices fell, street-level markets were restructured and offered heroin in addition to cocaine and crack (which had been popular during the 1980s). While officials estimate that there are between 500,000 and one million hard-core, chronic heroin users nationwide, evidence of supplemental users heralding another heroin era includes: more overdoses and overdose deaths, greater demand for treatment, larger seizures of heroin at all levels of distribution and related arrests, and broader media coverage. In this article, the authors describe the characteristics of populations in which there may have been a percentage increase of new users, such as young middle- or upper-class European-Americans, young Puerto Ricans and recent Haitian and Russian immigrants. The abstinence of young African-Americans is also noted. The article ends with a preliminary needs assessment of the new users in the areas of health (including AIDS), housing, employment, treatment, arrest and imprisonment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9460032     DOI: 10.1080/02791072.1997.10400565

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  14 in total

1.  The dynamics of heroin use; implications for intervention.

Authors:  T Millar; N Craine; T Carnwath; M Donmall
Journal:  J Epidemiol Community Health       Date:  2001-12       Impact factor: 3.710

Review 2.  The social course of drug injection and sexual activity among YMSM and other high-risk youth: an agenda for future research.

Authors:  Michael C Clatts; Lloyd Goldsamt; Alan Neaigus; Dorinda L Welle
Journal:  J Urban Health       Date:  2003-12       Impact factor: 3.671

3.  An invisible barrier to integrating HIV primary care with harm reduction services: philosophical clashes between the harm reduction and medical models.

Authors:  Daliah Heller; Kate McCoy; Chinazo Cunningham
Journal:  Public Health Rep       Date:  2004 Jan-Feb       Impact factor: 2.792

Review 4.  Updating the infection risk reduction hierarchy: preventing transition into injection.

Authors:  David Vlahov; Crystal M Fuller; Danielle C Ompad; Sandro Galea; Don C Des Jarlais
Journal:  J Urban Health       Date:  2004-03       Impact factor: 3.671

5.  Estimating the prevalence of injection drug users in the U.S. and in large U.S. metropolitan areas from 1992 to 2002.

Authors:  Joanne E Brady; Samuel R Friedman; Hannah L F Cooper; Peter L Flom; Barbara Tempalski; Karla Gostnell
Journal:  J Urban Health       Date:  2008-03-15       Impact factor: 3.671

6.  Estimating the prevalence of injection drug use among black and white adults in large U.S. metropolitan areas over time (1992--2002): estimation methods and prevalence trends.

Authors:  Hannah L F Cooper; Joanne E Brady; Samuel R Friedman; Barbara Tempalski; Karla Gostnell; Peter L Flom
Journal:  J Urban Health       Date:  2008-08-16       Impact factor: 3.671

7.  Projecting and Monitoring the Life Course of the Marijuana/Blunts Generation.

Authors:  Andrew Golub; Bruce D Johnson; Eloise Dunlap; Stephen Sifaneck
Journal:  J Drug Issues       Date:  2004

8.  Correlates and contexts of US injection drug initiation among undocumented Mexican migrant men who were deported from the United States.

Authors:  Angela M Robertson; Remedios Lozada; Robin A Pollini; Gudelia Rangel; Victoria D Ojeda
Journal:  AIDS Behav       Date:  2012-08

9.  White opioids: Pharmaceutical race and the war on drugs that wasn't.

Authors:  Julie Netherland; Helena Hansen
Journal:  Biosocieties       Date:  2017-06-28

10.  New injectors and the social context of injection initiation.

Authors:  Alex Harocopos; Lloyd A Goldsamt; Paul Kobrak; John J Jost; Michael C Clatts
Journal:  Int J Drug Policy       Date:  2008-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.